NCT07442578 2026-03-18
PULSE
Dana-Farber Cancer Institute
Phase NA Active not recruiting
Clinical Trials
5 trialsNCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
NCT04928261 2026-01-22
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT04892667 2025-08-13
DETECT
Assistance Publique - Hôpitaux de Paris
Phase NA Active not recruiting
NCT03748550 2024-08-21
EXACT2
Nova Scotia Health Authority
Phase NA Active not recruiting